- Lobbying
- Edward AND Allera
Lobbying Arrangements Results for 'Edward Allera'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Health Care and pharmaceutical issues. |
FERRING PHARMACEUTICALS - USA
Pharmaceuticals |
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Health care and pharmaceutical issues within the U.S. House and U.S. Senate. |
ELGE INC.
|
BUCHANAN INGERSOLL & ROONEY | |||
Details Health care and pharmaceutical issues within the U.S. House and U.S. Senate |
Sheffield Pharmaceuticals
Pharmaceutical Company |
Buchanan Ingersoll & Rooney | |||
Details Appropriations |
Warnex
Biotechnology company providing quality control products to agricultural, healthcare, pharmaceuti... |
BUCHANAN INGERSOLL, P.C. | |||
Details Objectives and Proposals |
Neurotechnology Industry Organization (NIO)
Phramaceutical |
BUCHANAN INGERSOLL, P.C. | |||
Details |
PHOENIX SCIENTIFIC, INC
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details FDA related Application issues; pricing of prescription drugs |
Breckenridge Pharmaceutical, Inc.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Congressional outreach and response to congressional inquiries and investigations regarding drug pricing |
Turing Pharmaceuticals
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Health care and pharmaceutical issues within the US House and US Senate. |
DESTON THERAPEUTICS, LLC
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Patent issues and health care reform |
STIEFEL LABORATORIES, INC.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Federal funding related to clinical trials for military PTSD; FY 2018 NDAA and Defense Appropriations |
Tonix Pharmaceuticals Holding Corp.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Strategy development and implementation of federal government relations initiatives; HR 3742, Antibiotic Development to Advance Patient Treatment; FDA compliance issues; HR 1919, Drug Supply Chain ... |
WOCKHARDT LTD
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Appropriations. |
TMO Renewables Ltd.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Biotech issues. US House and US Senate |
IDM Pharma Inc.
Biotech |
BUCHANAN INGERSOLL & ROONEY | |||
Details Strategy development and implementation of federal government relations initiatives regarding PDUFA/GDUFA reauthorization and generic pricing, Average Manufacturer Price proposed regulation. FDA pr... |
Concordia Healthcare Corp.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation |
WALGREEN CO.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Raise awareness of synthetic CBD for research and hemp legislation Raise awareness of synthetic CBD for research and hemp legislation; Advocate for inclusion of synthetic CBD in Farm Bill or other ... |
Zynerba Pharmaceuticals, Inc.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Strategy development and implementation of federal government relations initiatives regarding PDUFA reauthorization and generic pricing, Average Manufacturer Price proposed regulation. |
Concordia Pharmaceuticals, Inc.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Appropriations funding for Tuberculosis research and diagnostic testing initiatives. |
GENLANTIS (DIVISION OF GENE THERAPY SYSTEMS, INC.)
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Health care and pharmaceutical issues within the US House and US Senate. |
GRAS/E COALITION
Pharmaceutical |
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R... |
GENERIC ANIMAL DRUG ALLIANCE
|
Buchanan Ingersoll & Rooney, PC | |||
Details |
THE ROHO GROUP
|
BUCHANAN INGERSOLL, P.C. | |||
Details |
CROSS VETPHARM
|
BUCHANAN INGERSOLL, P.C. |